AbCellera Biologics Inc.
2.99
0.22 (7.94%)
At close: Jan 15, 2025, 11:59 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY01
Net Income -146.40M 158.52M 153.46M 118.92M -2.21M 309.00K n/a
Depreciation & Amortization 30.89M 33.10M 17.25M 5.27M 1.85M 918.00K n/a
Stock-Based Compensation 64.18M 49.48M 30.65M 8.40M 890.23K 615.00K n/a
Other Working Capital 56.01M 51.47M 36.74M 16.51M 3.78M 3.11M n/a
Other Non-Cash Items -7.74M 8.55M 3.57M 4.71M 194.19K -188.00K n/a
Deferred Income Tax 1.96M -2.11M -2.02M 2.10M n/a n/a n/a
Change in Working Capital 13.22M 29.82M 41.67M -116.70M 1.97M 1.91M n/a
Operating Cash Flow -43.88M 277.36M 244.58M 22.69M 2.69M 3.56M n/a
Capital Expenditures -77.51M -72.66M -58.45M -14.67M -4.00M -5.31M n/a
Acquisitions -13.69M -25.68M -41.78M -106.89M n/a n/a n/a
Purchase of Investments -1.07B -781.35M -292.24M -19.25M n/a n/a n/a
Sales Maturities Of Investments 910.94M 510.63M 27.61M 19.25M n/a n/a n/a
Other Investing Acitivies 25.31M 16.43M 32.62M 1.78M -1.78M n/a n/a
Investing Cash Flow -221.11M -352.63M -332.25M -119.78M -5.78M -5.31M n/a
Debt Repayment 11.59M 2.75M 5.49M 85.15M 180.66K 1.98M n/a
Common Stock Repurchased n/a n/a n/a n/a -11.15K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -1.23M -4.38M -9.37M 673.16M -10.83K 7.59M n/a
Financial Cash Flow 10.36M -1.63M -3.89M 683.65M 194.83K 12.19M n/a
Net Cash Flow -254.04M -86.49M -92.97M 586.56M -2.89M 10.44M n/a
Free Cash Flow -121.38M 204.70M 186.13M 8.02M -1.30M -1.74M n/a

Create Price Alert on ABCL

Your price alert will notify you when the stock price is above 2.99.

Add to Watchlist